Nonhormonal therapies for hot flashes in menopause

American Family Physician

Volumn 73, Issue 3, 2006, Pages 457-467

  Carroll, Dana G ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGELICA SINENSIS EXTRACT; BELLAMINE; BELLERGAL; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN RECEPTOR; FLUOXETINE; GABAPENTIN; GINSENG EXTRACT; ISOFLAVONE; MELATONIN; MIRTAZAPINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; PRIMROSE OIL; RED CLOVER EXTRACT; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TRAZODONE; VENLAFAXINE;

ANAMNESIS; ANGELICA SINENSIS; ANOREXIA; APPLICATION SITE IRRITATION; BLOOD VESSEL REACTIVITY; BREAST CANCER; CIMICIFUGA RACEMOSA; CLINICAL TRIAL; CONSTIPATION; DISEASE EXACERBATION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG INDUCED CANCER; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; ESTROGEN ACTIVITY; EVENING PRIMROSE; EXCITEMENT; GINSENG; HOT FLUSH; HUMAN; INSOMNIA; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; LUNG EMBOLISM; MENOPAUSE; NAUSEA; RED CLOVER; REVIEW; SIDE EFFECT; SOMNOLENCE; SOYBEAN; STROKE; TRANSDERMAL PATCH; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASOMOTOR REFLEX; XEROSTOMIA; YAM;

CIMICIFUGA; CLONIDINE; FEMALE; HOT FLASHES; HUMANS; ISOFLAVONES; MENOPAUSE; PHYTOTHERAPY; SEROTONIN UPTAKE INHIBITORS; SOYBEANS; TRIFOLIUM;

EID: 32244436543     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy menopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
2. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289:2827-34.
3. Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002;23:337-45.
4. Stearns V, Isaacs C, Rowland J, Crawford J, Ellis MJ, Kramer R, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann oncol 2000;11:17-22.
5. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin oncol 2002;20:1578-83.
6. Loprinzi CL, Pisansky TM, Fonseca R, Sloan JA, Zahasky KM, Quella SK, et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin oncol 1998;16:2377-81.
7. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000;356:2059-63.
8. Barton D, La VB, Loprinzi C, Novotny P, Wilwerding MB, Sloan J. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum 2002;29:33-40.
9. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005;105:161-6.
10. Goldberg RM, Loprinzi CL, O'Fallon JR, Veeder MH, Miser AW, Mailliard JA, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes [published correction appears in J Clin oncol 1996;14:2411]. J Clin oncol 1994;12:155-8.
11. Pandya KJ, Raubertas RF, Flynn PJ, Hynes HE, Rosenbluth RJ, Kirshner JJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical oncology Program study. Ann Intern Med 2000;132:788-93.
12. Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J obstet Gynecol 1987;156:561-5.
13. Scambia G, Mango D, Signorile PG, Anselmi Angeli RA, Palena C, Gallo D, et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7:105-11.
14. Penotti M, Fabio E, Modena AB, Rinaldi M, omodei U, Vigano P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril 2003;79:1112-7.
15. Van Patten CL, olivotto IA, Chambers GK, Gelmon KA, Hislop TG, Templeton E, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin oncol 2002;20:1449-55.
16. Burke GL, Legault C, Anthony M, Bland DR, Morgan TM, Naughton MJ, et al. Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause 2003;10:147-53.
17. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Center Treatment Group Trial. J Clin oncol 2000;18:1068-74.
18. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study [published correction appears in Menopause 2000;7:422]. Menopause 2000;7:236-42.
19. Faure E, Chantre P, Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2002;9:329-34.
20. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002;99:389-94.
21. Secreto G, Chiechi LM, Amadori A, Miceli R, Venturelli E, Valerio T, et al. Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. Maturitas 2004;47:11-20.
22. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001;8:17-26.
23. Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000;3:161-7.
24. Nikander E, Kilkkinen A, Metsa-Heikkila M, Adlercreutz H, Pietinen P, Tiitinen A, et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 2003;101:1213-20.
25. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.
26. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.
27. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) study. JAMA 2003;290:207-14.
28. van de Weijer PH, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187-93.
29. Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin oncol 2001;19:2739-45.
30. Stoll W. Phytopharmacon influences atrophic vaginal epithelium: double blind study - cimicifuga vs estrogenic substances. Therapeuticon 1987;1:23-31.
31. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNo 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44(suppl 1):S67-S77.
32. Hernandez Munoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 2003;44(suppl 1):S59-S65.
33. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizome): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 2002;11:163-74.
34. Berendsen HH. The role of serotonin in hot flushes. Maturitas 2000;36:155-64.
35. Boulet MJ, Oddens BJ, Lehert P, Vemer HM, Visser A. Climacteric and menopause in seven South-east Asian countries. Maturitas 1994;19:157-76.
36. Tang GW. The climacteric of Chinese factory workers. Maturitas 1994;19:177-82.
37. Albertazzi P, Purdie D. The nature and utility of the phytoestrogens: a review of the evidence. Maturitas 2002;42:173-85.
38. Farrell E. Medical choices available for management of menopause. Best Pract Res Clin Endocrinol Metab 2003;17:1-16.
39. American College of obstetricians and Gynecologists Committee on Practice Bulletins. Use of botanicals for management of menopausal symptoms. Obstet Gynecol 2001;97(suppl 1-11). Accessed online August 15, 2005 at: http://www.acog.org/from_home/publications/misc/pb028.htm.
40. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805-13.
41. Bodinet C, Freudenstein J. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation. Menopause 2004;11:281-9.
42. Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003;51:5661-70.
43. Borrelli F, Ernst E. Cimicifuga racemosa: a systematic review of its clinical efficacy. Eur J Clin Pharmacol 2002;58:235-41.
44. Bergmans MG, Merkus JM, Corbey RS, Schellekens LA, Ubachs JM. Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study. Maturitas 1987;9:227-34.
45. Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997;68:981-6.
46. Chenoy R, Hussain S, Tayob Y, O'Brien PM, Moss MY, Morse PF. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 1994;308:501-3.
47. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-45.
48. Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 1999;19:89-99
49. Waldinger MD, Berendsen HH, Schweitzer DH. Treatment of hot flushes with mirtazapine: four case reports. Maturitas 2000;36:165-8.
50. Pansini F, Albertazzi P, Bonaccorsi G, Zanotti L, Porto S, Dossi L, et al. Trazodone: a non-hormonal alternative for neurovegetative climacteric symptoms. Clin Exp obstet Gynecol 1995;22:341-4.
51. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin oncol 1998;16:495-500.
52. Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001;4:144-50.